Lone Pine Capital's 13F portfolio value increased slightly from $13.41B to $13.47B. Check out the new stakes and significant ...

This article was originally published on Quiver News, read the full story. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of ...

Q4 2024 Earnings Call Transcript March 24, 2025 Lucid Diagnostics Inc. misses on earnings expectations. Reported EPS is ...

The S&P 500 Index rose 25% in 2024, driven by strong earnings from tech stocks, especially the "Magnificent 7" benefiting ...

GameStop’s Q4 2024 earnings report was published at the close of markets today. The gaming retailer tallied $1.283 billion in ...

TECELRA® launch momentum accelerating – 10 patients apheresed in Q1 2025 and 3 in 2024; 20 ATCs available; all manufacturing and supply goals ...

We undertake no obligation to update ... over the next three years to further solidify efficient execution. Let me continue with a look back at what we have achieved in 2024.

Key Corporate and Program Updates CRB-701 for the treatment of solid tumors, is a next-generation antibody ... Ph1 China data presented at ASCO 2024 by our partner CSPC. No dose-limiting ...

MacroGenics (NASDAQ: MGNX) Q4 2024 Earnings Call Mar 20, 2025, 4:30 p.m. ET ...

And I’m extremely bullish on those things next three or ... fourth quarter of 2024, compared to $33.3 million in the previous quarter. Meanwhile, GAAP net income in Q4 2024 was $40.6 million ...

FY 2024 net sales[1] of USD 10.4 billion, up by 9%[2] in constant currencies (+7% in USD); Q4 net sales of USD 2. ... to publish its first-quarter sales update on April 30, 2025.

Key Corporate and Program Updates CRB-701 for the treatment ... Operating expenses for Q4 2024 increased by $2.5 million to approximately $12.6 million for the three months ended December ...